{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:23Z","timestamp":1793134103618,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Korea Institute of Drug Safety and Risk Management","award":["No. 20240417839-00"],"award-info":[{"award-number":["No. 20240417839-00"]}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["No. 21153MFDS601-1"],"award-info":[{"award-number":["No. 21153MFDS601-1"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00460379"],"award-info":[{"award-number":["RS-2024-00460379"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11314-1","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T17:43:59Z","timestamp":1753551839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adverse event reports of seizure for insomnia medication from 1967 to 2023"],"prefix":"10.1038","volume":"15","author":[{"given":"Tae Hyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesu","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanseul","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jeong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiseung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa J.","family":"Nehs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyoung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"11314_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.37765\/ajmc.2020.42769","volume":"26","author":"JA Dopheide","year":"2020","unstructured":"Dopheide, J. A. Insomnia overview: Epidemiology, pathophysiology, diagnosis and monitoring, and nonpharmacologic therapy. Am. J. Manag Care 26, 76-s84. https:\/\/doi.org\/10.37765\/ajmc.2020.42769 (2020).","journal-title":"Am. J. Manag Care"},{"key":"11314_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13311-021-01029-2","volume":"18","author":"NY Chan","year":"2021","unstructured":"Chan, N. Y., Chan, J. W. Y., Li, S. X. & Wing, Y. K. Non-pharmacological approaches for management of insomnia. Neurotherapeutics 18, 32\u201343. https:\/\/doi.org\/10.1007\/s13311-021-01029-2 (2021).","journal-title":"Neurotherapeutics"},{"key":"11314_CR3","first-page":"517","volume":"76","author":"K Ramakrishnan","year":"2007","unstructured":"Ramakrishnan, K. & Scheid, D. C. Treatment options for insomnia. Am. Fam Physician. 76, 517\u2013526 (2007).","journal-title":"Am. Fam Physician"},{"key":"11314_CR4","doi-asserted-by":"publisher","first-page":"e14035","DOI":"10.1111\/jsr.14035","volume":"32","author":"D Riemann","year":"2023","unstructured":"Riemann, D. et al. The European insomnia guideline: An update on the diagnosis and treatment of insomnia 2023. J. Sleep. Res. 32, e14035. https:\/\/doi.org\/10.1111\/jsr.14035 (2023).","journal-title":"J. Sleep. Res."},{"key":"11314_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s1087-0792(03)00025-x","volume":"8","author":"RD Jindal","year":"2004","unstructured":"Jindal, R. D. & Thase, M. E. Treatment of insomnia associated with clinical depression. Sleep. Med. Rev. 8, 19\u201330. https:\/\/doi.org\/10.1016\/s1087-0792(03)00025-x (2004).","journal-title":"Sleep. Med. Rev."},{"key":"11314_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/s0140-6736(22)00878-9","volume":"400","author":"F De Crescenzo","year":"2022","unstructured":"De Crescenzo, F. et al. Comparative effects of Pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet 400, 170\u2013184. https:\/\/doi.org\/10.1016\/s0140-6736(22)00878-9 (2022).","journal-title":"Lancet"},{"key":"11314_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","volume":"62","author":"K Alper","year":"2007","unstructured":"Alper, K., Schwartz, K. A., Kolts, R. L. & Khan, A. Seizure incidence in psychopharmacological clinical trials: an analysis of food and drug administration (FDA) summary basis of approval reports. Biol. Psychiatry. 62, 345\u2013354. https:\/\/doi.org\/10.1016\/j.biopsych.2006.09.023 (2007).","journal-title":"Biol. Psychiatry"},{"key":"11314_CR8","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/jnnp-2018-320215","volume":"90","author":"E Foster","year":"2019","unstructured":"Foster, E. et al. First seizure presentations in adults: Beyond assessment and treatment. J. Neurol. Neurosurg. Psychiatry 90, 1039\u20131045. https:\/\/doi.org\/10.1136\/jnnp-2018-320215 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"11314_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-024-01895-8","author":"S Kim","year":"2024","unstructured":"Kim, S. et al. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat. Hum. Behav. https:\/\/doi.org\/10.1038\/s41562-024-01895-8 (2024).","journal-title":"Nat. Hum. Behav."},{"key":"11314_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14010118","author":"Y Krutoshinskaya","year":"2024","unstructured":"Krutoshinskaya, Y., Coulehan, K., Pushchinska, G. & Spiegel, R. The reciprocal relationship between sleep and epilepsy. J. Pers. Med. 14, https:\/\/doi.org\/10.3390\/jpm14010118 (2024).","journal-title":"J. Pers. Med."},{"key":"11314_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/dom.16376","author":"TH Kim","year":"2025","unstructured":"Kim, T. H. et al. Adverse drug reaction patterns of GLP-1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database. Diabetes Obes. Metab. https:\/\/doi.org\/10.1111\/dom.16376 (2025).","journal-title":"Diabetes Obes. Metab."},{"key":"11314_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/all.16544","author":"J Cho","year":"2025","unstructured":"Cho, J. et al. TOP10-SCAR: A global pharmacovigilance study on medications most frequently related to severe cutaneous adverse reactions. Allergy https:\/\/doi.org\/10.1111\/all.16544 (2025).","journal-title":"Allergy"},{"key":"11314_CR13","doi-asserted-by":"publisher","first-page":"e29792","DOI":"10.1002\/jmv.29792","volume":"96","author":"S Lee","year":"2024","unstructured":"Lee, S. et al. Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967\u20132023: A comprehensive analysis of the international pharmacovigilance database. J. Med. Virol. 96, e29792. https:\/\/doi.org\/10.1002\/jmv.29792 (2024).","journal-title":"J. Med. Virol."},{"key":"11314_CR14","doi-asserted-by":"publisher","first-page":"16124","DOI":"10.1038\/s41598-024-67020-x","volume":"14","author":"SY Yoon","year":"2024","unstructured":"Yoon, S. Y. et al. Global burden of anticancer drug-induced acute kidney injury and tubulointerstitial nephritis from 1967 to 2023. Sci. Rep. 14, 16124. https:\/\/doi.org\/10.1038\/s41598-024-67020-x (2024).","journal-title":"Sci. Rep."},{"key":"11314_CR15","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.54724\/lc.2022.e8","volume":"2","author":"L Smith","year":"2022","unstructured":"Smith, L. et al. Global burden of disease study at the world health organization: research methods for the most comprehensive global study of disease and underlying health policies. Life Cycle. 2, e8. https:\/\/doi.org\/10.54724\/lc.2022.e8 (2022).","journal-title":"Life Cycle"},{"key":"11314_CR16","doi-asserted-by":"publisher","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","volume":"5","author":"M Barker-Haliski","year":"2015","unstructured":"Barker-Haliski, M. & White, H. S. Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harb Perspect. Med. 5, a022863. https:\/\/doi.org\/10.1101\/cshperspect.a022863 (2015).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"11314_CR17","doi-asserted-by":"publisher","first-page":"a022764","DOI":"10.1101\/cshperspect.a022764","volume":"6","author":"R Khazipov","year":"2016","unstructured":"Khazipov, R. GABAergic synchronization in epilepsy. Cold Spring Harb Perspect. Med. 6, a022764. https:\/\/doi.org\/10.1101\/cshperspect.a022764 (2016).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"11314_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/adm.0000000000001334","author":"J Laks","year":"2024","unstructured":"Laks, J. et al. Treating benzodiazepine withdrawal in a Bridge clinic. J. Addict. Med. https:\/\/doi.org\/10.1097\/adm.0000000000001334 (2024).","journal-title":"J. Addict. Med."},{"key":"11314_CR19","doi-asserted-by":"publisher","first-page":"24927","DOI":"10.52965\/001c.24927","volume":"9","author":"AN Edinoff","year":"2021","unstructured":"Edinoff, A. N. et al. Zolpidem: Efficacy and side effects for insomnia. Health Psychol. Res. 9, 24927. https:\/\/doi.org\/10.52965\/001c.24927 (2021).","journal-title":"Health Psychol. Res."},{"key":"11314_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.5664\/jcsm.7240","volume":"14","author":"G Chiaro","year":"2018","unstructured":"Chiaro, G., Castelnovo, A., Bianco, G., Maffei, P. & Manconi, M. Severe chronic abuse of zolpidem in refractory insomnia. J. Clin. Sleep. Med. 14, 1257\u20131259. https:\/\/doi.org\/10.5664\/jcsm.7240 (2018).","journal-title":"J. Clin. Sleep. Med."},{"key":"11314_CR21","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1021\/es203157f","volume":"46","author":"B Campos","year":"2012","unstructured":"Campos, B., Pi\u00f1a, B. & Barata, C. C. Mechanisms of action of selective serotonin reuptake inhibitors in Daphnia magna. Environ. Sci. Technol. 46, 2943\u20132950. https:\/\/doi.org\/10.1021\/es203157f (2012).","journal-title":"Environ. Sci. Technol."},{"key":"11314_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.yebeh.2016.03.022","volume":"61","author":"AM Kanner","year":"2016","unstructured":"Kanner, A. M. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence. Epilepsy Behav. 61, 282\u2013286. https:\/\/doi.org\/10.1016\/j.yebeh.2016.03.022 (2016).","journal-title":"Epilepsy Behav."},{"key":"11314_CR23","doi-asserted-by":"publisher","first-page":"e1226","DOI":"10.4088\/JCP.16m11377","volume":"78","author":"CS Wu","year":"2017","unstructured":"Wu, C. S., Liu, H. Y., Tsai, H. J. & Liu, S. K. Seizure risk associated with antidepressant treatment among patients with depressive disorders: A population-based case-crossover study. J. Clin. Psychiatry 78, e1226\u2013e1232. https:\/\/doi.org\/10.4088\/JCP.16m11377 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"11314_CR24","doi-asserted-by":"publisher","first-page":"107704","DOI":"10.1016\/j.neuropharm.2019.107704","volume":"172","author":"SJ Kaar","year":"2020","unstructured":"Kaar, S. J., Natesan, S., McCutcheon, R., Howes, O. D. & Antipsychotics Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology 172, 107704. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107704 (2020).","journal-title":"Neuropharmacology"},{"key":"11314_CR25","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1358\/dot.2003.39.7.799445","volume":"39","author":"D Hedges","year":"2003","unstructured":"Hedges, D., Jeppson, K. & Whitehead, P. Antipsychotic medication and seizures: a review. Drugs Today (Barc). 39, 551\u2013557. https:\/\/doi.org\/10.1358\/dot.2003.39.7.799445 (2003).","journal-title":"Drugs Today (Barc)"},{"key":"11314_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.nbd.2011.09.006","volume":"45","author":"L Rocha","year":"2012","unstructured":"Rocha, L. et al. Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy. Neurobiol. Dis. 45, 499\u2013507. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.006 (2012).","journal-title":"Neurobiol. Dis."},{"key":"11314_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.seizure.2012.10.009","volume":"22","author":"U Lertxundi","year":"2013","unstructured":"Lertxundi, U. et al. Antipsychotics and seizures: Higher risk with atypicals?. Seizure 22, 141\u2013143 (2013).","journal-title":"Seizure"},{"key":"11314_CR28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","volume":"64","author":"HY Meltzer","year":"2013","unstructured":"Meltzer, H. Y. Update on typical and atypical antipsychotic drugs. Annu. Rev. Med. 64, 393\u2013406. https:\/\/doi.org\/10.1146\/annurev-med-050911-161504 (2013).","journal-title":"Annu. Rev. Med."},{"key":"11314_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.23736\/s0392-0488.19.06274-6","volume":"154","author":"L Curto-Barredo","year":"2019","unstructured":"Curto-Barredo, L. & Gim\u00e9nez-Arnau, A. M. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine. G Ital. Dermatol. Venereol. 154, 444\u2013456. https:\/\/doi.org\/10.23736\/s0392-0488.19.06274-6 (2019).","journal-title":"G Ital. Dermatol. Venereol."},{"key":"11314_CR30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eplepsyres.2010.02.012","volume":"90","author":"TK Kukko-Lukjanov","year":"2010","unstructured":"Kukko-Lukjanov, T. K. et al. Involvement of histamine 1 receptor in seizure susceptibility and neuroprotection in immature mice. Epilepsy Res. 90, 8\u201315. https:\/\/doi.org\/10.1016\/j.eplepsyres.2010.02.012 (2010).","journal-title":"Epilepsy Res."},{"key":"11314_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pediatrneurol.2009.11.001","volume":"42","author":"T Takano","year":"2010","unstructured":"Takano, T. et al. Seizure susceptibility due to antihistamines in febrile seizures. Pediatr. Neurol. 42, 277\u2013279. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2009.11.001 (2010).","journal-title":"Pediatr. Neurol."},{"key":"11314_CR32","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1007\/s10072-021-05043-2","volume":"42","author":"H Kim","year":"2021","unstructured":"Kim, H., Kim, S. H. & Kim, J. B. Antihistamines as a common cause of new-onset seizures: A single-center observational study. Neurol. Sci. 42, 2505\u20132508. https:\/\/doi.org\/10.1007\/s10072-021-05043-2 (2021).","journal-title":"Neurol. Sci."},{"key":"11314_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006967.pub4","author":"F Brigo","year":"2016","unstructured":"Brigo, F. & Igwe, S. C. A. Melatonin as add-on treatment for epilepsy. Cochrane Database Syst Rev https:\/\/doi.org\/10.1002\/14651858.CD006967.pub4 (2016).","journal-title":"Cochrane Database Syst Rev"},{"key":"11314_CR34","doi-asserted-by":"publisher","first-page":"e12922","DOI":"10.1111\/jpi.12922","volume":"76","author":"Y Sun","year":"2024","unstructured":"Sun, Y. et al. Safety and efficacy of melatonin supplementation as an add-on treatment for infantile epileptic spasms syndrome: A randomized, placebo-controlled, double-blind trial. J. Pineal Res. 76, e12922. https:\/\/doi.org\/10.1111\/jpi.12922 (2024).","journal-title":"J. Pineal Res."},{"key":"11314_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1734-1140(11)70393-0","volume":"63","author":"M Banach","year":"2011","unstructured":"Banach, M., Gurdziel, E., J\u0119drych, M. & Borowicz, K. K. Melatonin in experimental seizures and epilepsy. Pharmacol. Rep. 63, 1\u201311. https:\/\/doi.org\/10.1016\/s1734-1140(11)70393-0 (2011).","journal-title":"Pharmacol. Rep."},{"key":"11314_CR36","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.54724\/lc.2024.e12","volume":"4","author":"J Jeong","year":"2024","unstructured":"Jeong, J., Jo, H., Park, J., Rahmati, M. & Pizzol, D. Regional burden of vaccine-associated menstrual disorders and sexual dysfunction: A retrospective study. Life Cycle 4, e12. https:\/\/doi.org\/10.54724\/lc.2024.e12 (2024).","journal-title":"Life Cycle"},{"key":"11314_CR37","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell, L. & Shakir, S. A. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 29, 385\u2013396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003 (2006).","journal-title":"Drug Saf."},{"key":"11314_CR38","doi-asserted-by":"publisher","first-page":"101689","DOI":"10.1016\/j.smrv.2022.101689","volume":"65","author":"J Lehner","year":"2022","unstructured":"Lehner, J., Frueh, J. S. & Datta, A. N. Sleep quality and architecture in idiopathic generalized epilepsy: A systematic review and meta-analysis. Sleep. Med. Rev. 65, 101689. https:\/\/doi.org\/10.1016\/j.smrv.2022.101689 (2022).","journal-title":"Sleep. Med. Rev."},{"key":"11314_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.04.039","author":"MS Kim","year":"2021","unstructured":"Kim, M. S. et al. Hepatobiliary adverse drug reactions associated with remdesivir: The WHO international pharmacovigilance study. Clin Gastroenterol. Hepatol https:\/\/doi.org\/10.1016\/j.cgh.2021.04.039 (2021).","journal-title":"Clin Gastroenterol. Hepatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11314-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:52:45Z","timestamp":1757296365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11314"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11314-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval for the use of confidential and electronically processed patient data was granted by the Institutional Review Board of Kyung Hee University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27308"}}